APOE genotype has a clear effect on astrocyte immune signaling, even in the absence of AD pathology, as evidenced by the 70% cross-validation accuracy and 95% confidence in our ability to predict genotype using our model. This evidence concerns the gene APOE and Alzheimer disease.